The postoperative use of Impella as a ventricular assist device in high-risk patients undergoing coronary artery bypass surgery: A case series and comparison.
Michel J SabraWeston G AndrewsMarie L CrandallJohn P PirrisPublished in: Journal of cardiac surgery (2019)
The postoperative use of the ICP heart pump, to support high-risk patients undergoing CABG, is a safe option. This practice has allowed us to perform CABG on sicker patients, specifically with depressed ejection fractions, with comparable results to the IABP. Further studies with larger patient populations are needed to draw definitive conclusions, but this pilot study demonstrates a possible expanded use of the Impella device.
Keyphrases
- coronary artery bypass
- patients undergoing
- percutaneous coronary intervention
- end stage renal disease
- heart failure
- newly diagnosed
- ejection fraction
- chronic kidney disease
- primary care
- peritoneal dialysis
- atrial fibrillation
- extracorporeal membrane oxygenation
- left ventricular
- case report
- left ventricular assist device